Neil Kumar is Chief Executive Officer of BridgeBio Pharma, Inc.. Currently has a direct ownership of 4.9 Million shares of BBIO, which is worth approximately $130 Million. The most recent transaction as insider was on Aug 16, 2022, when has been sold 27,697 shares (Common Stock) at a price of $11.08 per share, resulting in proceeds of $306,883. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.9M
0% 3M change
1.75% 12M change
Total Value Held $130 Million

Neil Kumar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 16 2022
SELL
Payment of exercise price or tax liability
$306,883 $11.08 p/Share
27,697 Reduced 0.57%
4,813,197 Common Stock
Aug 16 2022
BUY
Exercise of conversion of derivative security
-
68,705 Added 1.4%
4,840,894 Common Stock
May 16 2022
SELL
Payment of exercise price or tax liability
$160,136 $6.74 p/Share
23,759 Reduced 0.5%
4,772,189 Common Stock
May 16 2022
BUY
Exercise of conversion of derivative security
-
68,705 Added 1.41%
4,795,948 Common Stock
Feb 16 2022
SELL
Payment of exercise price or tax liability
$27,271 $8.84 p/Share
3,085 Reduced 0.07%
4,727,243 Common Stock
Feb 16 2022
BUY
Exercise of conversion of derivative security
-
7,524 Added 0.16%
4,730,328 Common Stock
Nov 16 2021
SELL
Payment of exercise price or tax liability
$176,242 $47.25 p/Share
3,730 Reduced 0.08%
4,722,804 Common Stock
Nov 16 2021
BUY
Exercise of conversion of derivative security
-
7,523 Added 0.16%
4,726,534 Common Stock
Aug 16 2021
SELL
Payment of exercise price or tax liability
$184,560 $49.48 p/Share
3,730 Reduced 0.08%
4,719,011 Common Stock
Aug 16 2021
BUY
Exercise of conversion of derivative security
-
7,523 Added 0.16%
4,722,741 Common Stock
May 16 2021
SELL
Payment of exercise price or tax liability
$200,205 $53.66 p/Share
3,731 Reduced 0.08%
4,715,218 Common Stock
May 16 2021
BUY
Exercise of conversion of derivative security
-
7,524 Added 0.16%
4,718,949 Common Stock
Feb 17 2021
BUY
Payment of exercise price or tax liability
$1,000,000 $62.5 p/Share
16,000 Added 0.34%
4,711,425 Common Stock
Feb 16 2021
SELL
Payment of exercise price or tax liability
$138,992 $64.98 p/Share
2,139 Reduced 0.05%
4,695,425 Common Stock
Feb 16 2021
BUY
Exercise of conversion of derivative security
-
5,129 Added 0.11%
4,697,564 Common Stock
Nov 16 2020
SELL
Payment of exercise price or tax liability
$78,641 $44.33 p/Share
1,774 Reduced 0.04%
4,692,435 Common Stock
Nov 16 2020
BUY
Exercise of conversion of derivative security
-
5,129 Added 0.11%
4,694,209 Common Stock
NK

Neil Kumar

Chief Executive Officer
Palo Alto, CA

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Track Activities on BBIO